998 related articles for article (PubMed ID: 17721194)
21. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
22. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
23. Expression of calretinin and the alpha-subunit of inhibin in granular cell tumors.
Fine SW; Li M
Am J Clin Pathol; 2003 Feb; 119(2):259-64. PubMed ID: 12579997
[TBL] [Abstract][Full Text] [Related]
24. CD56 expression in ovarian granulosa cell tumors, and its diagnostic utility and pitfalls.
Ohishi Y; Kaku T; Oya M; Kobayashi H; Wake N; Tsuneyoshi M
Gynecol Oncol; 2007 Oct; 107(1):30-8. PubMed ID: 17583777
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
26. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
[TBL] [Abstract][Full Text] [Related]
27. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.
Silva EG; Young RH
Am J Surg Pathol; 2007 Aug; 31(8):1203-8. PubMed ID: 17667544
[TBL] [Abstract][Full Text] [Related]
28. Testicular Sertoli cell tumor with a heterologous sarcomatous component: immunohistochemical assessment of Sertoli cell differentiation.
Gilcrease MZ; Delgado R; Albores-Saavedra J
Arch Pathol Lab Med; 1998 Oct; 122(10):907-11. PubMed ID: 9786352
[TBL] [Abstract][Full Text] [Related]
29. Sclerosing Sertoli cell tumor without expression of typical sex cord stromal tumor markers: case report and literature review.
Esber CM; Shabsigh A; Zynger DL
Pathol Res Pract; 2012 Feb; 208(2):121-5. PubMed ID: 22226390
[TBL] [Abstract][Full Text] [Related]
30. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors.
Iczkowski KA; Bostwick DG; Roche PC; Cheville JC
Mod Pathol; 1998 Aug; 11(8):774-9. PubMed ID: 9720507
[TBL] [Abstract][Full Text] [Related]
31. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.
Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA
Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065
[TBL] [Abstract][Full Text] [Related]
32. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.
Loy TS; Calaluce RD; Keeney GL
Mod Pathol; 1996 Nov; 9(11):1040-4. PubMed ID: 8933513
[TBL] [Abstract][Full Text] [Related]
33. Expression of galectin-3 in gonads and gonadal sex cord stromal and germ cell tumors.
Devouassoux-Shisheboran M; Deschildre C; Mauduit C; Berger G; Mejean-Lebreton F; Bouvier R; Droz JP; Fénichel P; Benahmed M
Oncol Rep; 2006 Aug; 16(2):335-40. PubMed ID: 16820912
[TBL] [Abstract][Full Text] [Related]
34. Metastatic ovarian Sertoli-cell tumor: FNA findings with immunohistochemistry.
Watson B; Siegel CL; Ylagan LR
Diagn Cytopathol; 2003 Nov; 29(5):283-6. PubMed ID: 14595797
[TBL] [Abstract][Full Text] [Related]
35. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
36. Differential diagnosis of mesothelial and ovarian cancer cells in ascites by immunocytochemistry using Ber-EP4 and calretinin.
Sato S; Okamoto S; Ito K; Konno R; Yajima A
Acta Cytol; 2000; 44(3):485-8. PubMed ID: 10834020
[No Abstract] [Full Text] [Related]
37. [Diagnostic value of immunohistochemistry in ovarian sex cord-stromal tumors].
Farah-Klibi F; Ben Slama S; Ben Hamouda S; Sfar R; Koubâa A; Ben Jilani S; Zermani R
Tunis Med; 2008 Sep; 86(9):821-6. PubMed ID: 19472783
[TBL] [Abstract][Full Text] [Related]
38. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
[TBL] [Abstract][Full Text] [Related]
39. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
McCluggage WG; Connolly LE; McBride HA; Kalloger S; Gilks CB
Histopathology; 2012 Mar; 60(4):547-53. PubMed ID: 22250726
[TBL] [Abstract][Full Text] [Related]
40. Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7.
Guerrieri C; Frånlund B; Malmström H; Boeryd B
Int J Gynecol Pathol; 1998 Jul; 17(3):266-71. PubMed ID: 9656124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
